Paloma Partners’s Milestone Scientific MLSS Stock Holding History

Paloma Partners’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-48,033	Closed	-$171K	–	2079
2021 Q1	$171K	Buy	+48,033	New	+$165K	﹤0.01%	1820

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Paloma Partners's MLSS Position: Q2 2021 in Review

Paloma Partners sold out of Milestone Scientific (MLSS) in Q2 2021, closing a stake of 48,033 shares — an estimated $171K sold.

Paloma Partners first reported a position in MLSS in Q1 2021 and held it in 1 quarter. The position peaked at $171K in Q1 2021. 45 funds tracked by Wall St. Rank hold MLSS as of Q2 2021.

Paloma Partners reported no remaining Milestone Scientific position as of Q2 2021 after selling out during the quarter.
Paloma Partners sold 48,033 Milestone Scientific shares in Q2 2021, an estimated $171K.
Paloma Partners first reported a position in Milestone Scientific in Q1 2021 and held it in 1 quarter.
Paloma Partners's Milestone Scientific position peaked at $171K in Q1 2021.
45 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.